Key facts
- Ventaris Surgical’s last known valuation is $79.0M (Mar 2026).
- It has raised $30.7M across 1 recorded rounds; the latest was Early Stage VC ($30.7M) in Jan 2026.
- Notable investors include Neotribe Ventures, Longitude Capital, Atypical Ventures, Boutique Venture Partners, SCP Ventures — 6 tracked in total.
- Ventaris Surgical has filed 1 Form D with the SEC, most recently Mar 2026 ($30.7M sold to 57 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Ventaris Surgical
Funding rounds
1 roundsAbout Ventaris Surgical
Developer of advanced surgical technologies designed to improve minimally invasive urological procedures. The company offers a next-generation ureteroscopic system that streamlines procedural steps and supports kidney stone management, enabling urologists and surgical teams to perform procedures more efficiently and with greater procedural control.
- Sector
- Healthcare
- HQ
- San Carlos, CA, United States
- Founded
- 2024
- Employees
- 9
- Website
- ventarissurgical.com/
- Ownership
- Privately Held (backing)
Ventaris Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ventaris Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ventaris Surgical in its N-PORT filings yet. We sweep new filings monthly.